Goldenwell Biotech, Inc. (GWLL) Research

Goldenwell Biotech, Inc. operates within the United States market, specializing in the development and distribution of nutraceuticals and dietary supplements. The company is actively developing a portfolio of five distinct products. These include JI MAI, a bovine cardiac vascular active peptide; cartilage peptide, which is a type II collagen peptide; and Double Proline AG, identified as a 3D active collagen peptide. The pipeline also features DNA repair tablets and sugar master tablets. Established in 2019, the firm maintains its headquarters in Twinsburg, Ohio.

Market snapshot

Symbol
GWLL
Price
$0.52
Day change
0.00%
Market cap
$51.5M
P/E ratio
-667.55x
52-week range
0.2-10
Sector
Consumer Defensive
Industry
Packaged Foods

Peer companies

  • Aryzta AG (ARZTY)
  • Ausnutria Dairy Corporation Ltd (AUDYF)
  • Grupo KUO, S.A.B. de C.V. (GKSDF)
  • Oceana Group Limited (OCGPF)
  • Origin Enterprises plc (ORENF)
  • PT Perusahaan Perkebunan London Sumatra Indonesia Tbk (PPLFY)
  • RCL Foods Limited (RCLFF)
  • Ridley Corporation Limited (RIDYF)

Open Goldenwell Biotech, Inc. (GWLL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.